CCO Treatment Updates

Novel Therapeutic Research and Priority Trials in Breast Cancer: An Online Clinical Management Series

Virtual Presentation

SLC Consensus on Research Priorities in Breast Cancer

Program Director: Edith A. Perez, MD

Faculty:

Edith A. Perez, MD

CREDIT INFORMATION

Release Date: 12/15/09

Expiration Date: 12/14/10

Physicians: maximum of 1.0 AMA PRA Category 1 Credit™

Status: Please log in to view status

In this Interactive Virtual Presentation, Edith A. Perez, MD, reviews high-priority research areas and clinical trials in breast cancer, as identified by the Breast Cancer Scientific Leadership Council.

Learning Objectives

Upon completion of this activity, participants should be able to:

Recall research priorities in the setting of breast cancer
Discuss the importance of randomized clinical trials in the setting of breast cancer
Articulate the utility of genetic profiling and the identification of prognostic and predictive markers in the setting of breast cancer treatment
Discuss current treatment of breast cancer, including screening, surgery, radiation, and pharmaceutical agents
Summarize key quality-of-life issues for breast cancer patients

Slideset: SLC Consensus on Research Priorities in Breast Cancer: Meeting Overview

Downloadable slideset which reviews the high-priority research areas and clinical trials in breast cancer, as identified by the Breast Cancer Scientific Leadership Council.

Format: Microsoft PowerPoint (.ppt) | File size: 2.01 MB | Date posted: 12/15/2009

Downloadable White Paper

Research Priorities in Breast Cancer: Recommendations of the Scientific Leadership Council in Breast Cancer of the Coalition of Cancer Cooperative Groups

Download PDF of white paper produced on recommendations of the SLC in Breast Cancer as presented at the Coalition of Cancer Cooperative Groups meeting in September 2008.

Download White Paper

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Contact Info

In association with

Educational grants provided by:

Educational grants support only the CME-certified components of this program.